| Pharmacologic treatment of stress urinary incontinence: expectations for outcome. | |
| | |
MedLine Citation:
|
PMID: 14550835 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Several classes of drugs have been investigated for their efficacy in treating stress urinary incontinence (SUI). Despite targeting the mechanisms known to be involved in maintaining continence, few have provided the desired benefits without causing significant adverse effects. Duloxetine, the newest drug to be extensively evaluated for SUI treatment, appears to be both safe and effective. None of the drugs tested thus far has proved to be curative, however. Treatment strategies therefore are aimed at improving the quality of life of patients and should take into account their individual needs and preferences. |
| | |
Authors:
|
Bernhard Schuessler; Kaven Baessler |
Related Documents
:
|
6135265 - Urinary incontinence secondary to drugs. 21414525 - Cannabinoid applications in glaucoma. 7969665 - Appetite regulation by serotoninergic mechanisms and effects of d-fenfluramine. 3429165 - The use of oxybutynin in urological practice. 14513375 - Miltefosine (impavido): the first oral treatment against leishmaniasis. 21756285 - A structure-based qsar and docking study on imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4,]... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Urology Volume: 62 ISSN: 1527-9995 ISO Abbreviation: Urology Publication Date: 2003 Oct |
Date Detail:
|
Created Date: 2003-10-10 Completed Date: 2003-11-05 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0366151 Medline TA: Urology Country: United States |
Other Details:
|
Languages: eng Pagination: 31-8 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Cantonal Hospital Lucerne, Lucerne, Switzerland. schuessler@tic.ch |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adrenergic Agents / pharmacology, therapeutic use Adrenergic Uptake Inhibitors / pharmacology, therapeutic use Adult Aged Drug Evaluation Estrogens / therapeutic use Exercise Therapy Female Humans Male Middle Aged Motor Neurons / drug effects, physiology Patient Satisfaction Pelvic Floor / physiopathology Quality of Life Serotonin Uptake Inhibitors / pharmacology, therapeutic use Thiophenes / therapeutic use Treatment Outcome Urinary Incontinence, Stress / drug therapy*, psychology, surgery, therapy |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic Agents; 0/Adrenergic Uptake Inhibitors; 0/Estrogens; 0/Serotonin Uptake Inhibitors; 0/Thiophenes; 116539-58-3/duloxetine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Home electrical stimulation for urinary incontinence: a study of the diffusion ofa new technology.
Next Document: Childbirth-induced trauma to the urethral continence mechanism: review and recommendations.